JP2008519067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519067A5 JP2008519067A5 JP2007540251A JP2007540251A JP2008519067A5 JP 2008519067 A5 JP2008519067 A5 JP 2008519067A5 JP 2007540251 A JP2007540251 A JP 2007540251A JP 2007540251 A JP2007540251 A JP 2007540251A JP 2008519067 A5 JP2008519067 A5 JP 2008519067A5
- Authority
- JP
- Japan
- Prior art keywords
- another example
- studies
- conducted
- producing
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001562 benzopyrans Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- UAJUXJSXCLUTNU-UHFFFAOYSA-N pranlukast Chemical compound C=1C=C(OCCCCC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1)=CC=C(C(C=2)=O)C=1OC=2C=1N=NNN=1 UAJUXJSXCLUTNU-UHFFFAOYSA-N 0.000 description 1
- 229960004583 pranlukast Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2004-0089455 | 2004-11-04 | ||
| KR1020040089455A KR101086254B1 (ko) | 2004-11-04 | 2004-11-04 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
| PCT/KR2005/003686 WO2006049433A1 (en) | 2004-11-04 | 2005-11-03 | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008519067A JP2008519067A (ja) | 2008-06-05 |
| JP2008519067A5 true JP2008519067A5 (enExample) | 2008-12-04 |
| JP5232472B2 JP5232472B2 (ja) | 2013-07-10 |
Family
ID=36319405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540251A Expired - Fee Related JP5232472B2 (ja) | 2004-11-04 | 2005-11-03 | 向上された生体利用効率を備えるプランルカスト固体分散体組成物およびその固体分散体の製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP5232472B2 (enExample) |
| KR (1) | KR101086254B1 (enExample) |
| AR (1) | AR051758A1 (enExample) |
| MX (1) | MX2007005427A (enExample) |
| TW (1) | TWI380829B (enExample) |
| WO (1) | WO2006049433A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101233235B1 (ko) * | 2005-08-26 | 2013-02-15 | 에스케이케미칼주식회사 | 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법 |
| EP2187968A4 (en) * | 2007-08-21 | 2013-02-20 | Univ Texas | THERMOKINETIC MIXING FOR PHARMACEUTICAL APPLICATIONS |
| EP4008314A3 (en) * | 2007-08-21 | 2022-11-09 | Board of Regents, The University of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| EP2140861A1 (en) * | 2008-06-30 | 2010-01-06 | Abbott GmbH & Co. KG | Pharmaceutical dosage form comprising polymeric carrier composition |
| GB201103837D0 (en) * | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
| KR101381881B1 (ko) * | 2012-03-12 | 2014-04-04 | 충남대학교산학협력단 | 용해도 및 용출율이 개선된 프란루카스트 나노 고체 분산체의 제조방법 |
| KR101446129B1 (ko) * | 2012-10-10 | 2014-10-06 | 조선대학교산학협력단 | 프란루카스트-함유 고형 제제의 제조방법 |
| KR102191562B1 (ko) * | 2012-11-07 | 2020-12-15 | 에스케이바이오팜 주식회사 | 난용성 약물의 고체분산체 및 이의 제조방법 |
| KR102363727B1 (ko) | 2015-06-01 | 2022-02-16 | 삼아제약 주식회사 | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 |
| WO2020012498A1 (en) | 2018-07-13 | 2020-01-16 | Council Of Scientific & Industrial Research | Solid dispersion comprising an anticancer compound with improved solubility and efficacy |
| KR20240164596A (ko) | 2023-05-09 | 2024-11-20 | 삼아제약 주식회사 | 복약편의성이 증진된 프란루카스트 함유 약제학적 조성물 |
| KR102840220B1 (ko) | 2023-07-18 | 2025-07-31 | 삼아제약 주식회사 | 프란루카스트 함유 약제학적 조성물의 제조방법 및 상기 제조방법에 의해 제조된 약제학적 조성물 |
| KR20250052834A (ko) | 2023-10-12 | 2025-04-21 | 주식회사 다산제약 | 프란루카스트의 생체이용률이 개선된 약제학적 조성물 및 그 제조방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19509807A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
| DE69625813T2 (de) * | 1995-06-12 | 2003-09-04 | Ono Pharmaceutical Co. Ltd., Osaka | Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast |
| US5858509A (en) * | 1996-11-15 | 1999-01-12 | Digital Equipment Corporation | Attenuating vibrations in a mounting shelf for multiple disk drives |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| KR100381834B1 (ko) * | 2000-05-20 | 2003-04-26 | 이상득 | 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법 |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
-
2004
- 2004-11-04 KR KR1020040089455A patent/KR101086254B1/ko not_active Expired - Lifetime
-
2005
- 2005-11-03 WO PCT/KR2005/003686 patent/WO2006049433A1/en not_active Ceased
- 2005-11-03 JP JP2007540251A patent/JP5232472B2/ja not_active Expired - Fee Related
- 2005-11-03 AR ARP050104618A patent/AR051758A1/es unknown
- 2005-11-03 MX MX2007005427A patent/MX2007005427A/es not_active Application Discontinuation
- 2005-11-04 TW TW094138786A patent/TWI380829B/zh not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008519067A5 (enExample) | ||
| NL301202I1 (nl) | Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline | |
| IL191711A0 (en) | 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors | |
| JP2009544651A5 (enExample) | ||
| JP2007302683A5 (enExample) | ||
| HUS1400056I1 (hu) | Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra | |
| WO2005055976A3 (de) | Pulver enthaltend niedermolekulares dextran und verfahren zu deren herstellung | |
| PL1740156T3 (pl) | Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej | |
| SI1689370T2 (sl) | Postopek za pripravo trdnega, oralno uporabnega farmacevtskega sestavka, ki obsega 5-klor-N(((5S)-2okso-3-(4-(3-okso-4-morfolinil)-fenil)-1,3-oksazolidin -5-il)-metil)-2-tiofenkarboksamid | |
| JP2004161535A5 (enExample) | ||
| WO2006082523A3 (en) | Pharmaceutical sustained release composition of metformin | |
| JP2009538861A5 (enExample) | ||
| WO2008130312A8 (en) | A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 | |
| JP2006339594A5 (enExample) | ||
| ATE531717T1 (de) | Neue kristalline form eines pyridazinoä4,5- büindolderivats | |
| IL180893A0 (en) | Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative | |
| SG170081A1 (en) | Method of patterning and product(s) obtained therefrom | |
| JP2006511228A5 (enExample) | ||
| WO2005121078A3 (de) | Substituierte cyclopenten-verbindungen | |
| TWI348593B (en) | Amine compound, chemically amplified resist composition and patterning process | |
| JP2008104450A5 (enExample) | ||
| WO2008065051A3 (de) | Herstellung von festen lösungen von pestiziden durch kurzzeitüberhitzung und schnelle trocknung | |
| IL190596A0 (en) | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
| WO2008074693A3 (en) | Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone | |
| IL187915A0 (en) | 1,2-di(cyclic group)substituted benzene derivative |